Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Pre-Payment of Loan in full availed from ICICI Bank Limited | 44.00 |
| 2 | To augment the existing and incremental working capital requirement of the Company | 8.50 |
| 3 | To meet General Corporate Purposes | 16.32 |
| Total | 68.82 |
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 48.60 | 41.22 | |
| Total Income | 22.08 | ||
| Profit After Tax | -7.80 | -4.69 | -0.84 |
| NET Worth | 41.73 | 33.35 | 43.36 |
| Total Borrowing | 32.88 | 6.16 | |
| Amount in ₹ Crore | |||
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the Registrar to the Issue | 0.04 |
| 2 | Fees payable to the Legal Advisors and other professional service providers | 0.26 |
| 3 | Advertising, marketing and shareholder outreach expenses | 0.04 |
| 4 | Fees payable to regulators, including Stock Exchanges, SEBI, depositories and other statutory fees | 0.10 |
| 5 | Printing and Stationery | 0.24 |
| 6 | Fees payable to Monitoring Agency | 0.06 |
| 7 | Statutory Auditors | 0.02 |
| 8 | Miscellaneous expenses and Stamp Duty | 0.05 |
| 9 | Others | 0.01 |
| Total | 0.82 |
Innovassynth Technologies Ltd is an India-based specialty chemicals company engaged in the research, development, and manufacturing of complex organic molecules and advanced chemical intermediates. The company primarily serves global pharmaceutical, agrochemical, and performance materials industries by offering contract research and manufacturing services (CRAMS) along with a portfolio of specialty chemicals and custom synthesis solutions.
With strong capabilities in process development, scale-up, and handling of complex chemistries, Innovassynth focuses on high-value, niche products that require technical expertise and stringent quality standards. The company operates integrated manufacturing facilities supported by dedicated R&D infrastructure, enabling it to deliver innovative, cost-effective, and compliant solutions to its international client base.
